Insider · CIK 0001226675

GREGORY JULIA P

Reports to the SEC for 5 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001226675

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-15	NRIXNurix Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+31.3K sh	—	—	31,250
2026-04-28	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Director	AAward	+68.7K sh	—	—	68,693
2025-09-17	NRIXNurix Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.8K sh	$1.86	+$20K	10,750
2025-09-17	NRIXNurix Therapeutics, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.8K sh	—	—	22,583
2025-05-19	NRIXNurix Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2025-05-05	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Director	AAward	+31.7K sh	—	—	31,716
2024-05-20	NRIXNurix Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-04-30	BHVNBiohaven Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+16.6K sh	—	—	16,592
2023-05-04	NRIXNurix Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-05-02	BHVNBiohaven Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+52.9K sh	—	—	52,906
2022-10-25	BHVNBiohaven Ltd.P Purchase	Director	PPurchase	+9,523 sh	$10.50	+$100K	25,665
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	Director	JOther	+5,998 sh	—	—	5,998
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	Director	JOther	+9,000 sh	—	—	9,000
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$2.33	+$21K	19,117
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+5,998 sh	$3.56	+$21.4K	10,117
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+4,119 sh	$4.84	+$19.9K	4,119
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,119 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,998 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	Director	AAward	+125K sh	—	—	125,000
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$3.06	+$27.5K	28,117
2022-10-03	BHVNBiohaven Ltd.F Tax Payment	Director	FTax Payment	−12K sh	$7.50	−$89.8K	16,142
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	Director	JOther	+4,119 sh	—	—	4,119
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	Director	JOther	+9,000 sh	—	—	9,000
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,239 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2022-05-05	NRIXNurix Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2022-04-28	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+8,239 sh	—	—	8,239
2021-12-20	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2021-12-20	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$23.63	+$284K	12,000
2021-12-20	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−12K sh	$125.00	−$1.5M	0
2021-05-06	NRIXNurix Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-05-05	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	11,996
2020-07-01	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−3,600 sh	$72.56	−$261K	0
2020-07-01	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	$28.76	+$518K	18,000
2020-07-01	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−14.4K sh	$71.20	−$1.03M	3,600
2020-07-01	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2020-04-30	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2019-11-22	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$23.63	+$284K	12,000
2019-11-22	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−12K sh	$54.75	−$657K	0
2019-11-22	Biohaven Pharmaceutical Holding Co Ltd.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	12,000
2019-05-21	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2019-02-21	Biohaven Pharmaceutical Holding Co Ltd.S Sale	Director	SSale	−12K sh	$43.56	−$523K	0
2019-02-21	Biohaven Pharmaceutical Holding Co Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$23.63	+$284K	12,000
2019-02-21	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	24,000
2018-05-01	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2017-08-02	Biohaven Pharmaceutical Holding Co Ltd.Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000

Recent filings

Accepted (ET)
May 154
GREGORY JULIA P0001226675-26-000004
SEC(opens sec.gov)
Apr 304
GREGORY JULIA P0001226675-26-000002
SEC(opens sec.gov)
Sep 174
GREGORY JULIA P0001226675-25-000004
SEC(opens sec.gov)
May 194
GREGORY JULIA P0001549595-25-000081
SEC(opens sec.gov)
May 74
GREGORY JULIA P0001935979-25-000043
SEC(opens sec.gov)
May 204
GREGORY JULIA P0001549595-24-000067
SEC(opens sec.gov)
May 24
GREGORY JULIA P0001562180-24-003753
SEC(opens sec.gov)
May 44
GREGORY JULIA P0001209191-23-027505
SEC(opens sec.gov)
May 44
GREGORY JULIA P0001562180-23-003944
SEC(opens sec.gov)
Oct 264
GREGORY JULIA P0001562180-22-007336
SEC(opens sec.gov)
Oct 54
GREGORY JULIA P0001562180-22-007079
SEC(opens sec.gov)

Companies

Address

C/O NURIX THERAPEUTICS, INC. 1600 SIERRA POINT PKWY

BRISBANE, CA, 94005